PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
14-May-2025 Join Parachute implementing Terumo Blood and Cell Technologies’ Rika Plasma Donation System to enhance donor experience and help expand access to lifesaving therapies Terumo Blood and Cell Technologies’
14-May-2025 NewBiologix Presents New Data at ASGCT on the Effective Manufacturing of rAAV-based therapeutics NewBiologix
14-May-2025 Canon Medical Systems UK Strengthens Presence in Veterinary Imaging with New Partnership Canon Medical Systems
14-May-2025 OncoZenge: Investor Receives NDRC Approval OncoZenge
14-May-2025 Coave Therapeutics Launches coAAV-CSF-01, a Novel CNS-Targeted Gene Therapy Vector for Neurodegenerative and other CNS Diseases Coave Therapeutics
14-May-2025 Leucid Bio Announces Treatment of First Patient in AERIAL Trial of NKG2D CAR-T Therapy LEU011 for Solid Tumours Leucid Bio
14-May-2025 Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) is an efficacious and well-tolerated long-acting growth hormone in children with growth disorders: results from REAL8 phase 3 basket study presented at the joint Congress of ESPE and ESE Novo Nordisk
14-May-2025 Almirall delivers a strong start to 2025: growing Q1 overall sales by 15%, and 23.4% in its European Dermatology business YoY, aligned with the company’s sustained growth trajectory Almirall
14-May-2025 Managing Director Peter Soelkner Leaves Role at Vetter Vetter
14-May-2025 ReiThera to Present Five Posters and Introduce New U.S. Business Development Lead at ASGCT 2025 ReiThera
14-May-2025 Resolution Therapeutics Announces Regenerative Macrophage Therapy (RMT) Manufacturing Process & Candidate Testing Suite at ASGCT 2025 Resolution Therapeutics
14-May-2025 RevoluGen and ProteoQuest Join Forces to Bring Fire Monkey HMW-DNA Extraction to China and Asia Pacific’s Fast Growing DNA Sequencing-based Genomics Markets RevoluGen
14-May-2025 Tiziana Life Sciences Announces Purchase of Shares by Chairman Tiziana Life Sciences
14-May-2025 Bayer confirms 2025 targets after solid start to the year Bayer
14-May-2025 New Breast Implant Closes the Reconstruction Gap for 1 in 7 Women After Breast Cancer Surgery Johnson & Johnson
14-May-2025 Ten-year APHINITY data show Roche’s Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancer Roche
14-May-2025 GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD) GSK
14-May-2025 Kaerus Bioscience’s lead candidate KER-0193 granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA for treatment of Fragile X syndrome (FXS) Kaerus Bioscience
13-May-2025 SMC approval of BALVERSA®▼ (erdafitinib) helps pave the way for first licensed bladder cancer therapy that specifically targets fibroblast growth factor receptor (FGFR3) alterations Johnson & Johnson
12-May-2025 Thermosome Receives U.S. Orphan Drug Designation for Lead Compound THE001, Expands Patent Estate Thermosome